HTA Co., Ltd. Obtained the Drug Registration Approval for the New Product

HTA Co., Ltd. Obtained the Drug Registration Approval for the New Product

2021-04-21
HTA Co., Ltd. (hereinafter referred to as HTA) recently received the drug registration approval for "Sodium Iodide [I-131] Capsules for Therapeutic Use" issued by the National Medical Products Adminis
HTA Co., Ltd. Signed a Technology Co-Development Agreement with FutureChem Co., Ltd

HTA Co., Ltd. Signed a Technology Co-Development Agreement with FutureChem Co., Ltd

2020-11-02
HTA Co., Ltd. (hereinafter referred to as “HTA”) signed a “Technology Co-Development Agreement” with FutureChem Co., Ltd (hereinafter referred to as “FutureChem”) on 9th September 2020.
HTA Will Launch the New Kr-85 Thickness Measurement Source on the Market

HTA Will Launch the New Kr-85 Thickness Measurement Source on the Market

2020-03-16
The new domestic Kr-85 thickness measurement source developed by HTA Co., Ltd. (hereinafter referred to as “HTA”) will be put on the market soon.
HTA Co., Ltd. Visiting Indonesia to Develop International Market

HTA Co., Ltd. Visiting Indonesia to Develop International Market

2020-01-16
HTA President Cui Haiping leads a team to visit Indonesia, negotiating with a Indonesian company and other potential project investors on radiopharmaceutical bussiness.